IRCT2014110618915N2已完成3 期
The effect of levamisole co-administration on the level of immune response to hepatitis B vaccine in healthy individuals.
Mashad University of Medical Sciences0 个研究点目标入组 217 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 217
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 70 years（—）
- 性别
- All
入选标准
- •16 years old and older without a history of a chronic disease or previous hepatitis B vaccination.
- •Exclusion criteria: current smoking and/or addiction to any form of drug; body mass index above 30 kg/m2; previous history of hepatitis B vaccination or infection; positive testing for HBs Ag or HBs Ab; any current chronic and/or acute disease.
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Evaluation of Levamisole efficacy in treatment of Covid-19IRCT20190810044500N7Yazd University of Medical Sciences50
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
招募中
2 期
Study lipase inhibitor and Alpha-glucosidase inhibitor in control of weight in obese patientIRCT20090317001774N9Kerman University of Medical Sciences90
已完成
2 期
Effect of levamisole adjuvant plus hepatitis B vaccine in vaccine non-responders health care workersHepatitis B vaccination.Need for immunization against viral hepatitisIRCT2014012110417N3Kermanshah University of Medical Sciences40
进行中（未招募）
1 期
AEUCTR2016-002324-92-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)156